Skip to main content
Fig. 1 | SpringerPlus

Fig. 1

From: Prognostic significance of platelet–lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer

Fig. 1

Receiver operator characteristic curves for the neutrophil-lymphocyte ratio (NLR) and the platelet–lymphocyte ratio (PLR). For NLR: area under the curve = 0.72, p = 0.002, sensitivity = 72.4%, specificity = 76.4%, accuracy = 74.6%. For PLR: area under the curve = 0.75, p = 0.001, sensitivity = 68.9%, specificity = 79.4%, accuracy = 73.0%

Back to article page